Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

August 11, 2022

1 minute read

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

UBS Offers To Buy Credit Suisse For Up To $1 Billion, But Proposal Seen As Too Low

March 19, 9:09 AM

UBS Group AG (NYSE: UBS) has offered to buy Credit Suisse Group AG (NYSE: CS) for up to $1 billion, according to the Financial Ti

July 11, 8:10 AM

Wells Fargo analyst Colin Langan maintains Autoliv (NYSE:ALV) with a Equal-Weight and raises the price target from $74 to $80.

April 3, 6:21 AM

The SU7 has a starting price of 215,900 yuan (about $29,838), lower than even the Tesla Model 3 in China.

November 11, 10:36 AM

Morgan Stanley analyst David Arcaro maintains Public Service Enterprise (NYSE:PEG) with a Overweight and raises the price target from $68 to $71.